SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-039116
Filing Date
2022-06-24
Accepted
2022-06-24 11:09:38
Documents
1
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4090
  Complete submission text file 0001209191-22-039116.txt   5447
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Issuer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CHIMERIX, INC. 2505 MERIDIAN PARKWAY, SUITE 340 DURHAM NC 27713
Business Address
Gilliss Catherine (Reporting) CIK: 0001611008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35867 | Film No.: 221038514